News

The company’s shares increased 5.2% in extended-hours trading as a result. Despite data indicating that the drug may increase the risk of heart attacks in some patients, the

Compared to the standard juvenile cells, adult Sertoli cells have enhanced protective properties that are particularly effective at protecting co-transplanted cells from being destroyed by the body’s immune

The Phase II study is an out-patient, dose-ranging clinical trial that will evaluate two dose levels of the single-dose, oral Ty800 vaccine and will follow each subject for

The lawsuit was filed by Ohio-based nonprofit organization Care to Live on July 30. The FDA made its decision not to approve the vaccine in May this year

The company based its decision on the vote by the oncologic drugs advisory committee (ODAC) to the FDA on July 24, 2007 that the FDA should wait for

The studies, conducted by teams of scientists working all over the world, will help shed light on the causes of multiple sclerosis (MS) according to the researchers. Both

Gene Logic discovered the new potential therapeutic use for the candidate, GL1001, using its drug repositioning platform, a set of drug evaluation technologies the company uses to assess

Medivation has expanded patient enrollment in the trial by 20% – to 90 patients – in order to enhance the ability to detect differences between Dimebon and placebo.

The vaccine, the first of its kind for 80 years, is needed following a global rise in TB outbreaks. In the UK alone, there has been a 10%